native glp-1 Understanding RA in Diabetes Structures of native GLP-1, exenatide,

Liraglutide (3.0 mg, daily subcutaneous injection, n=22) or semaglutide (1.0 mg, weekly subcutaneous injection, n=18) was started 74.5 (51.0, 108.3) months after surgery following a weight regain of 14.7 (10.3, 19.6)%

Furthermore, under clinical trial conditions Wegovy and tirzapetide continued to deliver significant, incremental weight loss until week 48, and even beyond for higher doses14

Free weight loss consultations available.

A new biweekly GLP-1 shot has been shown to significantly lower blood sugar and aid weight loss in a clinical trial, offering benefits similar to Ozempic and Mounjaro with fewer injections.

When comparing Semaglutide tablets vs